in-house Polypropylene Vials Manufacturing 

Equipped with modern moulding technology and advanced quality systems, the line is designed to meet stringent regulatory standards for manufacture of Plastic vials. Beyond in-house needs, the company aims to serve wider industry requirements, reinforcing its role as a reliable partner in healthcare solutions.

Details: –

Genetek Lifesciences Pvt. Ltd. has announced the start of plastic vial manufacturing at its Wardha facility. This expansion marks a strategic step toward building a fully integrated pharmaceutical operation, with packaging capabilities complementing its established formulations portfolio.

Plastic vials are increasingly gaining preference across the global pharmaceutical sector. Industry estimates suggest that the plastic pharmaceutical packaging market is expected to grow at a CAGR of approximately 9% through 2030, driven by the need for safer, more durable, and cost-efficient alternatives to glass. Compared to conventional glass containers, plastic vials are up to 80% lighter, significantly reducing logistics costs and breakage risks. Their durability and shatter-resistance also enhance safety during handling and transportation, while their adaptability makes them suitable for a wide range of sterile injectables and suspensions.

The Wardha unit is equipped with modern moulding technology and advanced quality control systems, ensuring that each vial produced meets stringent national and international regulatory standards. By manufacturing vials in-house, Genetek Lifesciences will be able to strengthen supply chain reliability, ensure consistency in quality, and reduce dependence on external suppliers.

The company expects the new line to serve both its internal production needs and create opportunities to provide vial solutions to other pharmaceutical manufacturers. This move positions Genetek as not only a medicine producer but also a contributor to the broader pharmaceutical ecosystem, supporting efficiency and safety in packaging.

Through this initiative, Genetek Lifesciences reinforces its commitment to innovation, infrastructure development, and long-term value creation, consolidating its role as a dependable partner in the Indian and global pharmaceutical markets.